Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-28T10:15:40.641Z Has data issue: false hasContentIssue false

Dementias

from Medical topics

Published online by Cambridge University Press:  18 December 2014

Jenny Rusted
Affiliation:
University of Sussex
Susan Ayers
Affiliation:
University of Sussex
Andrew Baum
Affiliation:
University of Pittsburgh
Chris McManus
Affiliation:
St Mary's Hospital Medical School
Stanton Newman
Affiliation:
University College and Middlesex School of Medicine
Kenneth Wallston
Affiliation:
Vanderbilt University School of Nursing
John Weinman
Affiliation:
United Medical and Dental Schools of Guy's and St Thomas's
Robert West
Affiliation:
St George's Hospital Medical School, University of London
Get access

Summary

Worldwide, we are currently witnessing an unprecedented demographic transformation, as life expectancy increases from the present 66 years of age to 77 years of age by 2050, and the proportion of the population over 60 doubles from 10 to 21%. A result of this increase in life expectancy is that the number of persons over the age of 60 years will rise from the current 600 million to around 1.5 billion by 2050. Britain will have over 6 million people over 75 years – double the 1985 figure, but significantly the great majority of older adults will reside in the less developed regions of the world (see also ‘Ageing and health behaviour’). Currently around 60% of the world's older population live in less developed countries, i.e. an estimated 279 million: by 2050 this proportion is projected to increased to 88%. This explosion in numbers of the over-70s will bring higher incidences of age-related illness and infirmity. Longevity is one of humanity's major achievements, but it brings with it the challenge to adjust our societies to this new reality by changing attitudes, introducing new political, social, health and economic measures that shift us from the current youthful pyramidal structures that are becoming obsolete in most world regions, though at a significantly faster rate in the more industrialized countries. Many less developed countries are currently experiencing a significant downturn in natural population increase (births minus deaths), similar to the decline that occurred in industrialized nations a few decades earlier.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Clare, L. & Woods, R.T. (2004). Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer's disease: a review. Neuropsychological Rehabilitation, 14, 385–401.Google Scholar
Blennow, K. & Vanmechelen, E. (2003). CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry. Brain Research Bulletin, 61, 235–42.Google Scholar
Braak, H. & Braak, E. (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging, 16, 271–8.Google Scholar
Diagnostic and Statistical Manual of Mental Disorders, version IV (2000).
Illife, S. (1997). Can delays in recognition of dementia in primary care be avoided?Aging & Mental Health, 1, 7–10.Google Scholar
Lee, H.B. & Lyketsos, C.G. (2003). Depression in Alzheimer's disease: heterogeneity and related issues. Biological Psychiatry, 54, 353–62.Google Scholar
Folstein, M.E., Folstein, S.E. & McHugh, P.R. (1975). Mini-mental state: a practical method for grading the cognitive state of patient by clinician. Journal of Experimental Psychology, 100, 221–7.Google Scholar
Grandmaison, E. & Simard, M. (2003). A critical review of memory stimulation programs in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 130–44.Google Scholar
Hardy, J. (2003). The genetics of Alzheimer's disease. In Iqbal, & Winblad, (Eds.). Alzheimer's disease and related disorders: research advances. Bucharest: Ana Aslan.
Rogers, S.L., Doody, R.S., Pratt, R.D. & Ieni, J.R. (2000). Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study. European Neuropsychopharmacology, 10, 195–203.Google Scholar
Rusted, J.M. & Clare, L. (2004). Cognitive approaches to the management of dementia. In Morris, & Becker, (Eds.). The Cognitive Neuropsychology of Alzheimer-Type Dementia (2nd edn.).

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×